Historical record - last NADAC effective date: 6/23/2021
Product Information
12-HR DECONGEST 120 MG CAPLET is a generic product labeled by Topco Associates LLC, priced at $0.2927 per EA under NDC 36800005452. Its NADAC has been published 397 times since Nov 28, 2013.
FDA first approved this application on Feb 26, 1999.
Strength
120 mg/1
Manufacturer
Topco Associates LLCNDC
36800005452
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075153FDA Approved
2/26/1999
On Market Since
4/25/2000
Pharmacological Classes
Price Statistics
The NADAC for 12-HR DECONGEST 120 MG CAPLET has been published 397 times since Nov 28, 2013, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2927 per EA |
|---|---|
| All-time high | $0.3768 (Aug 12, 2015) |
| All-time low | $0.2906 (May 19, 2021) |
| Median price | $0.3323 |
| Average price | $0.3333 |
| Largest weekly change | +11.0% (May 20, 2015) |
| Weeks tracked | 397 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-11.7%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pseudoephedrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of 12-HR DECONGEST 120 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for 12-HR DECONGEST 120 MG CAPLET, manufactured by Topco Associates LLC, is $0.2927 per EA (NDC 36800005452), effective Jun 30, 2021.
How has the price of 12-HR DECONGEST 120 MG CAPLET changed over time?
Over the history we have for it, the NADAC for 12-HR DECONGEST 120 MG CAPLET has declined 11.7%. It has been tracked across 397 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for 12-HR DECONGEST 120 MG CAPLET?
Since Nov 28, 2013, the NADAC for 12-HR DECONGEST 120 MG CAPLET has ranged from a low of $0.2906 (May 19, 2021) to a high of $0.3768 (Aug 12, 2015), with a median of $0.3323 per EA.
Are there cheaper alternatives to 12-HR DECONGEST 120 MG CAPLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM NASAL DECONGEST ER 120 MG, is $0.2756 per EA — about 6% below 12-HR DECONGEST 120 MG CAPLET.
Who manufactures 12-HR DECONGEST 120 MG CAPLET?
12-HR DECONGEST 120 MG CAPLET (NDC 36800005452) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.